论文部分内容阅读
在日前举办的第五届中国医药企业家高峰论坛上,有这样一家民营企业引起了大家的高度关注:这家几年前还名不见经传的小企业,近年来,平均每年以15%的速度快速增长,销售额在五年的时间内增加了两倍多,总资产由4000万元增加到了4亿余元;在业内可谓声誉鹊起。它就是广东华南药业集团。是什么样的力量让华南药业在短短五年时间内一跃而起,又是什么原因让它能够战胜多品种的困惑、市场的威胁而茁壮成长?带着诸多疑问,前不久,我们专访了华南药业集团董事长张绍日。
At the Fifth Summit of Chinese Pharmaceutical Entrepreneurs Summit held recently, such a private-owned enterprise aroused great concern from everyone. This small-scale, unknown enterprise a few years ago still has an average annual rate of 15% Rapid growth, sales in the five years time more than doubled, the total assets increased from 40 million yuan to 400 million yuan; in the industry can be described as the fame. It is Guangdong South China Pharmaceutical Group. What kind of power to make South China Pharmaceutical jumped up in just five years, and what makes it able to overcome the variety of puzzles, the threat of the market and thrive? With so many doubts, not long ago, we Interview with Zhang Shao-sun, chairman of South China Pharmaceutical Group.